{"id":15613,"date":"2021-11-29T11:36:00","date_gmt":"2021-11-29T10:36:00","guid":{"rendered":"https:\/\/convergences.online\/hemato\/?p=15613"},"modified":"2021-11-29T11:36:00","modified_gmt":"2021-11-29T10:36:00","slug":"un-peu-de-provocation-ne-fait-jamais-de-mal","status":"publish","type":"post","link":"https:\/\/www.hematostat.net\/en\/un-peu-de-provocation-ne-fait-jamais-de-mal\/","title":{"rendered":"Un peu de provocation ne fait jamais de mal"},"content":{"rendered":"<p>R\u00e9f :HematoStat.net ; 1 (11) : V28<\/p>\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34428511\/\">Van Gelder M, Tournilhac O, Te Raa D, Visser HPJ. Front-line chemo- immunotherapy is not inferior to ibrutinib in CLL. Ann Oncol. 2021 Nov;32(11):1442-1443. doi: 10.1016\/j.annonc.2021.08.1990. Epub 2021 Aug 21. PMID: 34428511.<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>R\u00e9f :HematoStat.net ; 1 (11) : V28 Van Gelder M, Tournilhac O, Te Raa D, Visser HPJ. Front-line chemo- immunotherapy is not inferior to ibrutinib in CLL. Ann Oncol. 2021 [&hellip;]<\/p>","protected":false},"author":9,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[11],"tags":[193,92,194],"ppma_author":[451],"class_list":["post-15613","post","type-post","status-publish","format-standard","hentry","category-veille-bibliographique","tag-essais-cliniques","tag-ibrutinib","tag-immunochimiotherapie","author-vincent-levy"],"aioseo_notices":[],"authors":[{"term_id":451,"user_id":9,"is_guest":0,"slug":"vincent-levy","display_name":"Vincent LEVY","avatar_url":{"url":"https:\/\/www.hematostat.net\/wp-content\/uploads\/2023\/06\/Capture-decran-2021-05-07-a-13.21.23.png","url2x":"https:\/\/www.hematostat.net\/wp-content\/uploads\/2023\/06\/Capture-decran-2021-05-07-a-13.21.23.png"},"first_name":"","last_name":"","user_url":"","description":"H\u00e9matologue, PU, PH en Pharmacie Clinique. <br>\r\nResponsable de l\u2019Unit\u00e9 de Recherche Clinique et du Centre de Recherche Clinique du GH de Seine-Saint-Denis, H\u00f4pital Avicenne. <br>\r\nMembre du CA et du CS du FILO. <br>\r\n<strong>Expertise : <\/strong>Leuc\u00e9mie lympho\u00efde chronique, essais cliniques.<br>\r\n<strong>Liens d'int\u00e9r\u00eat au 01\/01\/2023: <\/strong> Abbvie, AstraZeneca, Janssen.<br>\r\n<strong>Correspondance : <\/strong>H\u00f4pital Avicenne CRC\/URC, 125 rue de Stalingrad 96000 Bobigny."}],"_links":{"self":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/15613","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/comments?post=15613"}],"version-history":[{"count":0,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/15613\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/media?parent=15613"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/categories?post=15613"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/tags?post=15613"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/ppma_author?post=15613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}